Life-threatening ventricular arrhythmias

Drug	Drug Name	Drug Description
DB01035	Procainamide	A medication used to treat life threatening ventricular arrhythmias.
DB00489	Sotalol	A methane sulfonanilide beta adrenergic antagonist used to treat life-threatening ventricular arrhythmias and to maintain sinus rhythm in atrial fibrillation or flutter.

Drug	Drug Name	Target	Type
DB01035	Procainamide	Sodium channel protein type 5 subunit alpha	target
DB01035	Procainamide	DNA (cytosine-5)-methyltransferase 1	target
DB01035	Procainamide	Cytochrome P450 2D6	enzyme
DB01035	Procainamide	Cholinesterase	enzyme
DB01035	Procainamide	Solute carrier family 22 member 2	transporter
DB01035	Procainamide	Solute carrier family 22 member 1	transporter
DB01035	Procainamide	Solute carrier family 22 member 3	transporter
DB01035	Procainamide	Solute carrier family 22 member 5	transporter
DB01035	Procainamide	Solute carrier family 22 member 4	transporter
DB01035	Procainamide	Potassium voltage-gated channel subfamily H member 2	target
DB01035	Procainamide	Multidrug and toxin extrusion protein 1	transporter
DB01035	Procainamide	Multidrug and toxin extrusion protein 2	transporter
DB00489	Sotalol	Potassium voltage-gated channel subfamily H member 2	target
DB00489	Sotalol	Beta-1 adrenergic receptor	target
DB00489	Sotalol	Beta-2 adrenergic receptor	target
DB00489	Sotalol	Cytochrome P450 2D6	enzyme

Drug	Drug Name	Phase	Status	Count